Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02768571 : Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke
PhasePhase 4
AgesMin: 19 Years Max: 80 Years
Eligibility
Inclusion Criteria:

1. The first-ever stroke (ischemic)

2. Confirmed by CT or MRI

3. Subacute stage: less than 1 week

4. Severe motor function involvement (FMA < 50)

5. Age: between 19 and 80 years

6. Inpatients

7. Written informed consent obtained from the patient or legally authorized
representative

Exclusion Criteria:

1. Contraindication of MRI

2. Progressive or unstable stroke

3. Pre-existing and active major neurological disease

4. Pre-existing and active (e.g., on chronic medication) major psychiatric disease, such
as major depression, schizophrenia, bipolar disease, or dementia

5. A history of significant alcohol or drug abuse in the prior 3 years

6. Advanced liver, kidney, cardiac, or pulmonary disease

7. A terminal medical diagnosis consistent with survival < 1 year

8. Substantial decrease in alertness at the time of randomization, defined as score of 2
on NIH Stroke Scale

9. Pregnancy or lactating; note that a negative pregnancy test will be required if the
patient is a female in reproductive years

10. Any condition that would represent a contraindication to Cerebrolysin, including
allergy to Cerebrolysin

11. Current enrolment in another therapeutic study of stroke or stroke recovery

12. Total serum bilirubin > 4 mg/dL, alkaline phosphatase > 250 U/L, SGOT/AST > 150 U/L,
SGPT/ALT > 150 U/L, or creatinine > 3.5 mg/dL; or cardiopulmonary deficits large
enough to interfere with reasonable participation in physiotherapy during the trial.

13. Previous porcine brain peptide administration history
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02768571      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740